MIRA INFORM REPORT

 

 

Report Date :

16.06.2014

 

IDENTIFICATION DETAILS

 

Name :

CLAROCHEM IRELAND LIMITED

 

 

Registered Office :

Damastown, Mulhuddart, Dublin 15, 216410

 

 

Country :

Ireland

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

06.02.1991

 

 

Com. Reg. No.:

IE169797

 

 

Legal Form :

Private Company

 

 

Line of Business :

Manufacture of basic pharmaceutical products

 

 

No. of Employees :

37

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

Slow but correct

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

Ireland

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


 

IRELAND - ECONOMIC OVERVIEW

 

Ireland is a small, modern, trade-dependent economy. Ireland was among the initial group of 12 EU nations that began circulating the euro on 1 January 2002. GDP growth averaged 6% in 1995-2007, but economic activity has dropped sharply since the onset of the world financial crisis. Ireland entered into a recession in 2008 for the first time in more than a decade, with the subsequent collapse of its domestic property market and construction industry. Property prices rose more rapidly in Ireland in the decade up to 2007 than in any other developed economy. Since their 2007 peak, average house prices have fallen 47%. In the wake of the collapse of the construction sector and the downturn in consumer spending and business investment, the export sector, dominated by foreign multinationals, has become an even more important component of Ireland's economy. Agriculture, once the most important sector, is now dwarfed by industry and services. In 2008 the former COWEN government moved to guarantee all bank deposits, recapitalize the banking system, and establish partly-public venture capital funds in response to the country's economic downturn. In 2009, in continued efforts to stabilize the banking sector, the Irish Government established the National Asset Management Agency (NAMA) to acquire problem commercial property and development loans from Irish banks. Faced with sharply reduced revenues and a burgeoning budget deficit, the Irish Government introduced the first in a series of draconian budgets in 2009. In addition to across-the-board cuts in spending, the 2009 budget included wage reductions for all public servants. These measures were not sufficient to stabilize Ireland’s public finances. In 2010, the budget deficit reached 32.4% of GDP - the world's largest deficit, as a percentage of GDP - because of additional government support for the country’s deeply troubled banking sector. In late 2010, the former COWEN government agreed to a $92 billion loan package from the EU and IMF to help Dublin recapitalize Ireland’s fragile banking sector and avoid defaulting on its sovereign debt. Since entering office in March 2011, the new KENNY government has intensified austerity measures to try to meet the deficit targets under Ireland's EU-IMF program. Ireland has grown slowly since 2011, but managed to reduce the budget deficit to 7.2% of GDP in 2013. In late 2013, Ireland formally exited its EU-IMF bailout program, benefiting from its strict adherence to deficit-reduction targets and success in refinancing a large amount of banking-related debt.

 

Source : CIA

 

 

 

 


REGISTERED NAME & COMPANY SUMMARY

 

Company Name:           CLAROCHEM IRELAND LIMITED

Company No:                IE169797

Registered Address:      DAMASTOWN

MULHUDDART

DUBLIN 15

216410

 

 

Company information

 

Registered Address:      DAMASTOWN

MULHUDDART

DUBLIN 15

216410

Trading Address :          Arthur Cox Building, Earlsfort Terrace, 

Dublin 2

Dublin 2

216410

Telephone Number :      018206111

TPS :                            No

FPS :                            No

Incorporation Date :       06.02.1991

Type :                           Other

Currency :                     EUR

Share Capital :                          €3,532,000

SIC07 :                         21100

SIC07 Description :       MANUFACTURE OF BASIC PHARMACEUTICAL PRODUCTS

Principal Activity :         The development, manufacture and sale of active pharmaceutical ingredients. 

 

 

DIRECTORS/MANAGEMENT

 

Total Current Directors

3

Total Current Secretaries

1

Total Previous Directors / Company Secretaries

14

 

Current Directors

Name

ROBERTO ANGELO FUSCO

Date of Birth

21/12/1941

Officers Title

 

Nationality

 

Present Appointments

1

Function

Director

Appointment Date

18/06/2009

 

 

Address

VIA GIOVANNI PASCOLI, 70/4, 20133 MILAON, ITALY

Other Actions

View Director Report

 

 

Disqualified

 

Disqualified End Date

 

Disqualification Exception

No

 

 

 

Name

BRIAN JOSEPHY KEAVENY

Date of Birth

17/01/1963

Officers Title

 

Nationality

 

Present Appointments

1

Function

Director

Appointment Date

18/06/2009

 

 

Address

11 HAMPTON PARK, ST HELENS WOOD, BOOTERSTOWN, CO DUBLIN

Other Actions

View Director Report

 

 

Disqualified

 

Disqualified End Date

 

Disqualification Exception

No

 

 

 

Name

SANTE LANZI

Date of Birth

17/06/1962

Officers Title

 

Nationality

 

Present Appointments

1

Function

Director

Appointment Date

29/06/2010

 

 

Address

VIALE VITTORIO VENETO, 18 20124, MILANO, ITALY

Other Actions

View Director Report

 

 

Disqualified

 

Disqualified End Date

 

Disqualification Exception

No

 

 

 

Current Company Secretary

Name

THE SECRETARIAL COMPANY LIMITED

Date of Birth

08/02/1991

Officers Title

 

Nationality

 

Present Appointments

143

Function

Company Secretary

Appointment Date

18/06/2009

 

 

Address

 

 

 

 

Previous Director/Company Secretaries

Name

Current Directorships

Previous Directorships

BRADWELL LIMITED

1097

643

PAOLO DERMITZEL

0

2

LUIGI CALETTI

3

2

CARLOS VON BONHORST

0

1

THEUNIS YDE STEENSMA

0

1

ROLF WANDELER

0

1

GABRIELE BRAGLIA

0

1

ENRICO BRAGLIA

0

5

RICCARDO BRAGLIA

4

2

VINCENT ARTHUR GABRIEL WALSH

18

25

CLAUDIO REBUZZINI

0

1

SIMONE REBUZZINI

0

1

DECLAN HAYES

67

54

PAUL MICHIEL VAN LIENDEN

3

2

 

 

NEGATIVE INFORMATION

 

CJ

Total Number of Exact CJs -

0

Total Value of Exact CJs -

€0

Total Number of Possible CJs -

0

Total Value of Possible CJs -

€0

Total Number of Satisfied CJs -

0

Total Value of Satisfied CJs -

€0

 

Possible CJ Details

There are no possible CJ details

 

Unregistered - Exact CJ Details

No CJs found

 

Unregistered - Possible CJ Details

No CJs found

 

Registered - Exact CJ Details

No CJs found

 

Registered - Possible CJ Details

No CJs found

 

 

SHARE & SHARE CAPITAL INFORMATION

 

Top 20 Shareholders

Name

Currency

Share Count

Share Type

Nominal Value

% of Total Share Count

MEDINCO SPA

EUR

3,532,000

ORDINARY

1

100

 

 

PAYMENT INFORMATION

 

Creditor Details

 

Total Number

Total Value

Trade Creditors

0

-

 

No Creditor Data

 

Trade Debtors / Bad Debt Detail

 

Total Number of Documented Trade

Total Value of Documented Trade

Trade Debtors

-

-

 

No Debtor Data

 

Average Invoice Value

n/a

Invoices available

n/a

Paid

n/a

Outstanding

n/a

 

Trade Payment Data is information that we collect from selected third party partners who send us information about their whole sales ledger.

 


 

 

Within Terms

0-30 Days

31-60 Days

61-90 Days

91+ Days

Paid

 

 

 

 

 

Outstanding

 

 

 

 

 

 

 

GROUP STRUCTURE & AFFILIATED COMPANIES

 

Statistics

Group

2 companies

Linkages

3 companies

Countries

In 1 countries

 

Summary

Holding Company

-

Ownership Status

Wholly Owned

Ultimate Holding Company

MEDINCO S.P.A.

 

Group structure

Company Name

 

Registered Number

Latest Key Financials

Consol. Accounts

Turnover

MEDINCO S.P.A.

 

04441340157

31.12.2011

-

€40,591

CLAROCHEM IRELAND LIMITED

 

IE169797

31.12.2012

N

 

 

Statistics

Group

2 companies

Linkages

3 companies

Countries

In 1 countries

 

Other Linked companies

Name

 

Number

Latest Key Financials

Turnover

C.F.M. CO.FARMACEUTICA MILANESE -S.P.A.

 

MI381251

31.12.2012

€10,466,692

COSMA - S.P.A.

 

BG167479

31.12.2012

€24,883,153

A.M.S.A. ANONIMA MATERIE SINTETICHE E AFFINI S.P.A.

 

MI601857

31.12.2012

€23,936,910

 

FINANCIAL INFORMATION

 

Profit & Loss

 

Date Of Accounts

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

(%)

31/12/08

Weeks

52

(%)

52

(%)

52

(%)

52

(%)

52

Currency

EUR

(%)

EUR

(%)

EUR

(%)

EUR

(%)

EUR

Consolidated A/cs

N

(%)

N

(%)

N

(%)

N

(%)

N

Turnover

-

-

-

-

-

-

-

-

€7,704,808

Export

-

-

-

-

-

-

-

-

€3,357,278

Cost of Sales

-

-

-

-

-

-

-

-

-

Gross Profit

€2,971,309

-16.4%

€3,553,896

37.1%

€2,592,588

-28.8%

€3,640,182

-

-

Wages & Salaries

€1,934,333

1.9%

€1,898,022

9%

€1,741,100

-6.4%

€1,860,100

-6.6%

€1,991,744

Directors Emoluments

€183,666

-5.2%

€193,731

-2.3%

€198,310

-

-

-100%

€13,000

Operating Profit

-€1,132,025

-121.1%

-€511,937

69%

-€1,653,087

-212.8%

-€528,398

-

-

Depreciation

€752,877

-8.5%

€822,418

-3%

€847,542

-3.3%

€876,755

-7.1%

€944,212

Audit Fees

-

-

€13,500

-1.8%

€13,750

-9.4%

€15,172

-24.3%

€20,030

Interest Payments

€44,613

6.5%

€41,886

386.7%

€8,607

53.3%

€5,615

-2.9%

€5,781

Pre Tax Profit

-€1,176,634

-112.5%

-€553,810

66.7%

-€1,661,646

-215.5%

-€526,645

-153.5%

€984,882

Taxation

€17,113

-74.2%

€66,385

23%

€53,981

-14.7%

€63,252

999.9%

-€6,128

Profit After Tax

-€1,159,521

-137.9%

-€487,425

69.7%

-€1,607,665

-246.9%

-€463,393

-147.3%

€978,754

Dividends Payable

-

-

-

-

-

-

-

-

-

Retained Profit

-€1,159,521

-137.9%

-€487,425

69.7%

-€1,607,665

-246.9%

-€463,393

-147.3%

€978,754

 

Balance Sheet

 

Date Of Accounts

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

(%)

31/12/08

Tangible Assets

€4,144,819

-0.9%

€4,182,076

-6.2%

€4,456,616

-12.2%

€5,077,011

-13.2%

€5,850,731

Intangible Assets

0

-

0

-

0

-

0

-

0

Total Fixed Assets

€4,144,819

-0.9%

€4,182,076

-6.2%

€4,456,616

-12.2%

€5,077,011

-13.2%

€5,850,731

Stock

€1,779,960

56%

€1,140,914

20.4%

€947,542

-6.1%

€1,008,740

-66.4%

€3,005,581

Trade Debtors

€1,362,825

-51.5%

€2,809,920

79.6%

€1,564,578

-4.8%

€1,643,957

139.4%

€686,597

Cash

€15,697

-94.7%

€294,147

165.7%

€110,712

-33.9%

€167,442

-95.5%

€3,719,855

Other Debtors

€169,107

-48.3%

€327,180

110.5%

€155,399

19.8%

€129,730

-86.6%

€967,427

Miscellaneous Current Assets

0

-

0

-

0

-

0

-

0

Total Current Assets

€3,327,589

-27.2%

€4,572,161

64.6%

€2,778,231

-5.8%

€2,949,869

-64.8%

€8,379,460

Trade Creditors

€911,239

-21.9%

€1,167,111

27.8%

€913,256

72.3%

€530,160

485.3%

€90,584

Bank Loans & Overdrafts

€400,946

-34.3%

€610,171

-2.4%

€624,907

249.3%

€178,891

-

0

Other Short Term Finance

€674,892

-29.2%

€953,796

999.9%

€57,505

25.2%

€45,943

999.9%

€2,798

Miscellaneous Current Liabilities

€75,808

2.3%

€74,115

51.3%

€48,991

-22.6%

€63,299

-93.8%

€1,027,333

Total Current Liabilities

€2,062,885

-26.5%

€2,805,193

70.6%

€1,644,659

101%

€818,293

-27%

€1,120,715

Bank Loans & Overdrafts and LTL

€1,960,916

-35.7%

€3,050,141

37.5%

€2,218,596

24.4%

€1,783,314

999.9%

€50,939

Other Long Term Finance

€1,559,970

-36.1%

€2,439,970

55.4%

€1,569,980

-

€1,569,980

-

0

Total Long Term Liabilities

€1,559,970

-36.1%

€2,439,970

53.1%

€1,593,689

-0.7%

€1,604,423

999.9%

€50,939

 

Capital & Reserves

 

Date Of Accounts

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

(%)

31/12/08

Called Up Share Capital

€3,532,000

73.8%

€2,032,000

-

€2,032,000

-

€2,032,000

-

€2,032,000

P & L Account Reserve

€317,553

-78.5%

€1,477,074

-24.8%

€1,964,499

-45%

€3,572,164

-67.6%

€11,026,537

Revaluation Reserve

-

-

-

-

-

-

-

-

-

Sundry Reserves

-

-

-

-

-

-

-

-

-

Shareholder Funds

€3,849,553

9.7%

€3,509,074

-12.2%

€3,996,499

-28.7%

€5,604,164

-57.1%

€13,058,537

 

Other Financial Items

 

Date Of Accounts

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

(%)

31/12/08

Net Worth

€3,849,553

9.7%

€3,509,074

-12.2%

€3,996,499

-28.7%

€5,604,164

-57.1%

€13,058,537

Working Capital

€1,264,704

-28.4%

€1,766,968

55.9%

€1,133,572

-46.8%

€2,131,576

-70.6%

€7,258,745

Total Assets

€7,472,408

-14.6%

€8,754,237

21%

€7,234,847

-9.9%

€8,026,880

-43.6%

€14,230,191

Total Liabilities

€3,622,855

-30.9%

€5,245,163

62%

€3,238,348

33.7%

€2,422,716

106.8%

€1,171,654

Net Assets

€3,849,553

9.7%

€3,509,074

-12.2%

€3,996,499

-28.7%

€5,604,164

-57.1%

€13,058,537

 

Cash Flow

 

Date Of Accounts

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

(%)

31/12/08

Net Cashflow from Operations

-€575,273

-163.3%

-€218,457

34.9%

-€335,583

-119.7%

€1,705,275

61.9%

€1,053,036

Net Cashflow before Financing

-€1,290,321

-70.8%

-€755,625

-50.3%

-€502,746

90.6%

-€5,344,629

-690%

€905,946

Net Cashflow from Financing

€1,500,000

-

-

-

-

-100%

€1,613,125

290.3%

€413,352

Increase in Cash

€209,679

127.7%

-€755,625

-50.3%

-€502,746

86.5%

-€3,731,504

-382.8%

€1,319,298

 

Miscellaneous

 

Date Of Accounts

31/12/12

(%)

31/12/11

(%)

31/12/10

(%)

31/12/09

(%)

31/12/08

Contingent Liability

NO

-

NO

-

NO

-

NO

-

YES

Capital Employed

€5,409,523

-9.1%

€5,949,044

6.4%

€5,590,188

-22.5%

€7,208,587

-45%

€13,109,476

Number of Employees

37

2.8%

36

16.1%

31

-

31

-8.8%

34

Auditors

RSM FARRELL GRANT SPARKS

Auditor Comments

The audit report contains no adverse comments

Bankers

BANK OF IRELAND

Bank Branch Code

90-04-20

 

Ratios

 

Date Of Accounts

31/12/12

31/12/11

31/12/10

31/12/09

31/12/08

Pre-tax profit margin %

-

-

-

-

12.78

Current ratio

1.61

1.63

1.69

3.60

7.48

Sales/Net Working Capital

-

-

-

-

1.06

Gearing %

50.90

86.90

55.50

31.80

0.40

Equity in %

51.50

40.10

55.20

69.80

91.80

Creditor Days

-

-

-

-

4.27

Debtor Days

-

-

-

-

32.43

Liquidity/Acid Test

0.75

1.22

1.11

2.37

4.79

Return On Capital Employed %

-21.75

-9.30

-29.72

-7.30

7.51

Return On Total Assets Employed %

-15.74

-6.32

-22.96

-6.56

6.92

Current Debt Ratio

0.53

0.79

0.41

0.14

0.08

Total Debt Ratio

0.94

1.49

0.81

0.43

0.08

Stock Turnover Ratio %

-

-

-

-

39

Return on Net Assets Employed %

-30.56

-15.78

-41.57

-9.39

7.54

 

 

FOREIGN EXCHANGE RATES

 

Na

 

 


ADDITIONAL INFORMATION

 

Commentary

No exact match CCJs are recorded against the company.                                                 

There is insufficient data to indicate a change in this company's percentage of sales.        

Net Worth increased by 9.7% during the latest trading period.                                           

 

A 14.6% decline in Total Assets occurred during the latest trading period.                         

Pre-tax profits decreased by 112.5% compared to the previous trading period.                 

The company saw a decrease in their Cash Balance of 94.7% during the latest trading period.     

The audit report contains no adverse comments.                                                              

The company has undergone recent changes in its directorships.                                      

The company is part of a group.                                                                                      

The company was established over 23 years ago.                                                            

 

Status History

No Status History found

 

Event History

Date

Description

08/10/2013

New Accounts Filed

08/10/2013

New Accounts Filed

07/10/2013

Annual Returns

07/06/2013

SIMONE REBUZZINI has left the board

07/06/2013

CLAUDIO REBUZZINI has left the board

13/09/2012

New Accounts Filed

12/09/2012

Annual Returns

04/10/2011

New Accounts Filed

04/10/2011

New Accounts Filed

03/10/2011

Annual Returns

22/09/2010

Annual Returns

22/09/2010

New Accounts Filed

22/09/2010

New Accounts Filed

29/06/2010

New Board Member (SANTE LANZI) appointed

12/04/2010

Annual Returns

 

Previous Company Names

No Previous Names found

 

 

NOTES & COMMENTS

 

Na


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.59.48

UK Pound

1

Rs.100.93

Euro

1

Rs.80.71

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

NNA

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.